MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive gain
-$96,499K
(12.11%↑ Y/Y)
Interest and other income
(expense), net
$9,867K
(0.03%↑ Y/Y)
Change in fair value of
derivative liabilities
$2,500K
(10.62%↑ Y/Y)
Change in fair value of
contingent consideration...
-$514K
(-2003.70%↓ Y/Y)
Change in fair value of
non-controlling equity...
$16K
(100.77%↑ Y/Y)
Net gain
-$94,318K
(13.68%↑ Y/Y)
Unrealized gain (loss) on
marketable securities
-$2,181K
(-320.23%↓ Y/Y)
Total other income
(expense)
$12,897K
(28.76%↑ Y/Y)
Loss from operations
-$107,215K
(10.12%↑ Y/Y)
License and
collaboration revenue
$31,738K
(324.87%↑ Y/Y)
Total operating
expenses
$138,953K
(9.62%↑ Y/Y)
Research and development
$104,524K
(5.78%↑ Y/Y)
General and
administrative
$34,429K
(23.22%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM)